Fol. Biol. 2007, 53, 143-145
https://doi.org/10.14712/fb2007053040143
Risedronate Has No Adverse Effects on Mouse Haematopoiesis
References
1. , K. T., Šefc, L., Pšenák, O., Vokurka, M., Nečas, E. (2005) Early fetal liver readily repopulates B-lymphopoiesis in adult bone marrow. Stem Cells 23, 230-239.
<https://doi.org/10.1634/stemcells.2004-0069>
2. , P. (2001) The hematopoietic stem cell and the stromal microenvironment. Therapie 56, 383-384.
3. , F., Le Gall, C., Gasser, J., Green, J., Clezardin, P. (2007) Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. J. Natl. Cancer Inst. 99, 322-330.
<https://doi.org/10.1093/jnci/djk054>
4. , P., Boissier, S., Filleur, S., Guglielmi, J., Cabon, F., Colombet, M., Clezardin, P. (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res. 62, 6538-6544.
5. , I., Haggstrom S., Damber, J. E., Bergh, A. (1998) Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 139, 451-456.
<https://doi.org/10.1210/endo.139.2.5683>
6. J. (1967) An improved automated procedure for the determination of calcium in biological specimens. Anal. Biochem. 18, 521-531.
<https://doi.org/10.1016/0003-2697(67)90110-8>
7. , M. (2004) Mesenchymal stem cells: biological characteristics and potential clinical application. Cloning Stem Cells 6, 369-337.
<https://doi.org/10.1089/clo.2004.6.369>
8. J. (1966) A semiautomated determination of phospholipids. Clin. Chim. Acta 13, 442-448.
<https://doi.org/10.1016/0009-8981(66)90235-X>
9. , A. A., Halasy-Nagy, J. M., Masarachia P. J., Rodan, G. A. (1999) bisphophonates act directly on the osteoclast to induce caspase cleavage of Mst1 kinase during apoptosis. J. Biol. Chem. 274, 34967-34973.
<https://doi.org/10.1074/jbc.274.49.34967>
10. , M., Gordon, S., Benford, H. L., Coxon, F. P., Luskman, S. P., Monkkonen, J., Frith, J. C. (2000) Cellular and molecular mechanism of action of bisphoshonates. Cancer 86, 2061-2978.
11. , A., Rutledge, S. J., Endo, N., Opas, E. E., Tanaka, H., Weselowski, G., Leu, C. T., Huang, Z., Ramachandaran, C., Rodan, S. B., Rodan, G. A. (1996) Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by aledronate. Proc. Natl. Acad. Sci. USA 93, 3068-3073.
<https://doi.org/10.1073/pnas.93.7.3068>
12. , J., Bonjean, K., Ruetz, S., Bellahcene, A., Devy, L., Foidart, J. M., Castronovo, V., Green, J. R. (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J. Pharm. Exp. Ther. 302, 1055.
<https://doi.org/10.1124/jpet.102.035295>
